Autobrains
Autobrains, an automotive AI powerhouse, is unveiling its new groundbreaking AI technology, Liquid AI, which effectively tackles the three major challenges in today's automotive AI landscape - covering edge cases, achieving a viable cost point, and bridging the gap between perception and decision.
TEL AVIV, ISRAEL and MUNICH, GERMANY / ACCESSWIRE / March 13, 2024 / Autobrains, a leader in automotive AI headquartered in Tel Aviv, introduces its latest breakthrough: Liquid AI. Liquid AI represents a paradigm shift in autonomous driving and Advanced Driver Assistance Systems (ADAS), addressing challenges that even the best automotive companies struggle to overcome. It combines Autobrains' signature-based self-learning approach with a modular and adaptive architecture of specialized, scenario-based end-to-end skills. "While current technologies perform well in handling average conventional driving tasks, they fall short when faced with unexpected real-world driving scenarios that demand greater precision. By using or implementing our Liquid AI, automotive companies can close their AI gaps," adds Autobrains' Founder and CEO, Igal Raichelgauz.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.The Challenges Faced by Conventional AI Systems:
- Edge Cases: The infinite variety of unexpected driving scenarios presents conventional AIs with practically unsolvable tasks. Today's manually trained black-box systems cannot cover edge cases. Attempts to address this by feeding the systems more labeled images result in a loss of trackability and controllability.
- Cost: Addressing real-world driving problems by expanding existing systems with more data, labeling, layers, and computational resources leads to escalating costs and power consumption, resulting in diminishing returns. Achieving a substantial improvement in system accuracy by a factor of 10 requires 10,000 times more computational resources.
- Perception-Decision Disconnect: The missing interplay between perception and decision functions hinders effective and precise decision-making. For the AI to make optimal driving choices, it requires specific information. However, when details are missing or overly complex, precision is compromised, leading to incorrect reactions.
Liquid AI - Human Brain-Inspired:
Autobrains draws inspiration from the human brain, which consists of specialized areas akin to task-specific narrow end-to-end AIs. Just as our brain adapts its architecture based on context - such as light/weather conditions, surroundings, and relevant road users - Liquid AI follows the same approach. Here's how it works:
- Network of Specialized Narrow AIs: Liquid AI comprises hundreds of thousands of specialized narrow AIs, each designed for specific tasks, making reactions very precise and tailored to the relevant driving scenario. This specialized AI approach enables scalability, ranging from a few tens to hundreds of AIs for ADAS systems, scaling up to thousands for higher levels of automated driving, all the way to hundreds of thousands of AIs for full self-driving.
- Adaptive Architecture: Unlike fixed systems, Liquid AI's architecture adapts dynamically to the driving context, activating only relevant modules as necessary. This significantly reduces power consumption and compute requirements, not only resulting in cost savings for the System on Chip (SoC) hardware.
- Efficiency and Precision: By mimicking the brain's flexibility, Liquid AI achieves superior performance, cost-effectiveness, and safety.
The Future of Automotive Intelligence:
Autobrains' Liquid AI bridges the gap between conventional AI limitations and the promise of truly intelligent autonomous systems. By mimicking the human brain's flexibility, Liquid AI achieves superior performance, cost-effectiveness, and more explainability and controllability.
About Autobrains
Autobrains is a leading AI company in the automotive industry. Autobrains invented and developed a paradigm-shifting AI technology: Liquid AI - backed by 250+ patents addressing autonomous driving challenges. Implementing this unique AI technology for ADAS applications disrupts the market with its unprecedented perception capabilities, low compute requirements, and agnosicity to sensors and SoCs. The company is backed by strategic investors including Temasek, Knorr-Bremse AG, BMW i Ventures, Toyota Ventures, VinFast, Continental AG, and Autel.
Learn more: https://autobrains.ai.
Contact: sales@autobrains.ai
Contact Information
Sophia Eichler
Director of Marketing
media@autobrains.ai
+49 015167066494
SOURCE: Autobrains
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 202617.11.2025 03:05:00 CET | Press release
Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE / ACCESS Newswire / November 16, 2025 / Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab. In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea. "Adding AEW&C to the MQ-9B bring
Doha Tattoo Festival Announced as Ticket Sales Officially Open16.11.2025 12:45:00 CET | Press release
DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village. A press conference held at Katara Cultural Village unveiled the line-up of participating bands and ticket details, attended by members of the Doha Tattoo organising committee and partner representatives. The Doha Tattoo will combine precision with musical artistry, showcasing performances by distinguished musical bands from seven countries: the United Kingdom, the United States of America, Turkia, Hashemite Kingdom of Jordan , the Sultanate of Oman, Kazakhstan, and the State of Qatar. The participating line-up includes the Irish Guards and the Royal Air Force Music Services from the United Kingdom, the United States Air Force
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom